Specifically, the KEAP1 genetic alterations were described by Fernandez-Cuesta et al. as a new uncovered molecular hallmark of the Lung LCNEC (Large Cell Neuroendocrine Carcinoma) group with adenocarcinoma-like features [7]. The gene discussed is KEAP1; the disease is adenocarcinoma.